Self-renewing Islet TCF1+ CD8 T cells undergo IL-27-controlled differentiation to become TCF12 terminal effectors during the progression of type 1 diabetes
Ashley E. Ciecko, David M. Schauder, Bardees Foda, Galina Petrova, Moujtaba Y. Kasmani, Robert Burns, Chien Wei Lin, William R. Drobyski, Weiguo Cui*, Yi Guang Chen
Dive into the research topics of 'Self-renewing Islet TCF1+ CD8 T cells undergo IL-27-controlled differentiation to become TCF12 terminal effectors during the progression of type 1 diabetes'. Together they form a unique fingerprint.